Raberitun Tablet 20 mg (Rabeprazole Sodium)

Adult dose

For gastric ulcer and duodenal ulcer: Administer 10 mg orally once a day, and based on symptoms, 20 mg orally once a day may be administered. Treatment duration is up to 8 weeks for gastric ulcer, and 6 weeks for duodenal ulcer. For erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once a day for 4 to 8 weeks. If untreated, an additional 8 weeks of 10 mg or 20 mg may be taken orally twice a day.

This medication should not be used by patients with specific allergic reactions, pregnant women, or breastfeeding women. Patients with poor liver function, the elderly, and those with allergies to specific dyes should use this medication with caution. If allergy symptoms such as skin rash or itching occur while taking this medication, discontinuation should be immediate. Regular blood tests and liver function tests are required, and if any abnormalities are found, immediate consultation with a physician is necessary. Side effects may occur in various systems including the heart, gastrointestinal tract, nervous system, respiratory system, and skin, so careful observation is needed if symptoms arise. Due to the drug's action of inhibiting gastric acid secretion, long-term use may increase the risk of bone fractures, therefore, long-term use should be according to a physician's directions. Additionally, long-term use may lower magnesium levels, so regular blood tests for monitoring are necessary. There may be an increased risk of gastrointestinal bacterial infections, so if symptoms such as diarrhea or abdominal pain persist, notify a healthcare professional immediately. Caution is required as drowsiness or dizziness may occur while driving or operating machinery. There may be interactions with other medications taken with this drug, so it is essential to inform the physician or pharmacist of any current medications. It is safest not to use this medication during pregnancy or breastfeeding. It is advisable not to use in children as safety has not been established. There are no specific antidotes for overdose, so in case of suspicion, immediately visiting a medical facility for appropriate treatment is necessary. Tablets should be swallowed whole, not chewed or crushed, and kept out of the reach of children. For long-term use of this medication, regular medical examinations and tests as necessary are important.

Serious side effects

Hives, severe swelling (edema), tightness in the chest, difficulty breathing, fulminant hepatitis, liver dysfunction, jaundice, serious skin adverse reactions (toxic epidermal necrolysis, Stevens-Johnson syndrome), acute interstitial nephritis, angioedema, anaphylaxis, sudden death, coma, rhabdomyolysis, perceptual disturbances, delirium, hypotension, severe edema, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular or urticarial rashes

Mild side effects

• Rash
• itching
• decreased red blood cells
• decreased white blood cells
• increased white blood cells
• increased eosinophils
• increased neutrophils
• decreased lymphocytes
• anemia
• petechiae

This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. A storage temperature of 1 to 30 degrees Celsius is recommended. By storing it this way, the drug's effectiveness and safety can be preserved for a long time.

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets/Alu-Alu (14 tablets/Alu-Alu * 2)